Komori
GLOME Holdings (8938) · RiskMitigated

Risk of joint and several guarantee obligations for SPC borrowings

First written in FY2017. 21 of 30 entries say "Mitigated", first in FY2020-Q2. Latest entry: FY2027-H1.

30entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2018-Q3 – FY2020-Q1MitigatedFY2021-Q2 – FY2027-H12017: 120172018: 420182019: 420192020: 320202021: 420212022: 420222023: 320232024: 320242025: 220252026: 22026
Same theme, other companies
Guarantees of borrowings by third partiesA theme 24 companies write about · 24 as a headwind · 0 as a tailwind

GLOME Holdings moved to the "Worse" side of this theme in 2018, 2 years before the typical company in this theme (2020).

The whole theme swung hardest in 2018: 4 of 13 companies on the "Worse" side.

14 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 24 companies compared. The sentences above are computed from all 24.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥288 million — million; Medical Corporation Nogakikai (borrowings) ¥67 million ¥58 million; Medical Corporation Junseikai (borrowings) ¥21 million ¥21 million; Total ¥376 million ¥79 million」

    Guarantees of debt owed by medical corporations decreased from ¥376 million at the end of the previous fiscal year to ¥79 million, reducing guarantee exposure.
  2. 2026-05-28MitigatedGeneral Meetings of Shareholders

    「医療法人について、金融機関等からの借入に対し、保証を行っています。医療法人樹恵会(借入債務)288百万円 医療法人野垣会(借入債務)67百万円 医療法人社団潤清会(借入債務)21百万円 計376百万円」

    医療法人に対する保証債務残高が376百万円と具体的に示された。直近のFY2026-H1記載の392百万円から減少している。
  3. FY2026-H1MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥334 million ¥299 million Medical Corporation Nogakikai (borrowings) ¥71 million ¥71 million Medical Corporation Junseikai (borrowings) ¥21 million ¥21 million Total ¥427 million ¥392 million」

    The balance of guarantees of debt to medical corporations decreased from ¥427 million at the end of the previous fiscal year to ¥392 million, reducing guarantee exposure.
  4. FY2025MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥406 million ¥334 million Medical Corporation Nogakikai (borrowings) ¥76 million ¥71 million Social Medical Corporation Hannan Medical and Welfare Center (borrowings) ¥1,506 million ¥0 million Medical Corporation Junseikai (borrowings) ¥23 million ¥21 million Total ¥2,012 million ¥427 million」

    The balance of guarantees of debt to medical corporations decreased substantially from ¥2,012 million at the end of the previous fiscal year to ¥427 million, and guarantees to Social Medical Corporation Hannan Medical and Welfare Center also fell to zero.
  5. FY2025-H1MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥406 million ¥370 million Medical Corporation Nogakikai (borrowings) ¥76 million ¥71 million Social Medical Corporation Hannan Medical and Welfare Center (borrowings) ¥1,506 million ¥0 million Medical Corporation Junseikai (borrowings) ¥23 million ¥21 million Total ¥2,012 million ¥463 million」

    The balance of guarantees of debt to medical corporations decreased substantially from ¥2,012 million at the end of the previous consolidated fiscal year to ¥463 million, and guarantees to Social Medical Corporation Hannan Medical and Welfare Center also fell to zero. quantified is true, materialized is false.
  6. FY2024MitigatedAnnual report

    「Total ¥2,186 million ¥2,012 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,186 million at the end of the previous fiscal year to ¥2,012 million, reducing guarantee exposure.
  7. FY2024-Q3MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥477 million ¥424 million Medical Corporation Nogakikai (borrowings) ¥114 million ¥81 million Social Medical Corporation Hannan Medical and Welfare Center (borrowings) ¥1,567 million ¥1,523 million Medical Corporation Junseikai (borrowings) ¥26 million ¥24 million Total ¥2,186 million ¥2,052 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,186 million at the end of the previous consolidated fiscal year to ¥2,052 million, reducing guarantee exposure.
  8. FY2024-Q2MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥477 million ¥442 million Medical Corporation Nogakikai (borrowings) ¥114 million ¥85 million Social Medical Corporation Hannan Medical and Welfare Center (borrowings) ¥1,567 million ¥1,539 million Medical Corporation Junseikai (borrowings) ¥26 million ¥25 million Total ¥2,186 million ¥2,092 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,186 million at the end of the previous consolidated fiscal year to ¥2,092 million.
  9. FY2024-Q1MitigatedAnnual report

    「Medical Corporation Jukeikai (borrowings) ¥477 million ¥459 million Medical Corporation Nogakikai (borrowings) ¥114 million ¥88 million Social Medical Corporation Hannan Medical and Welfare Center (borrowings) ¥1,567 million ¥1,550 million Medical Corporation Junseikai (borrowings) ¥26 million ¥25 million Total ¥2,186 million ¥2,124 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,186 million at the end of the previous consolidated fiscal year to ¥2,124 million at the end of the first quarter under review.
  10. FY2023-Q3MitigatedAnnual report

    「Total ¥2,454 million ¥2,272 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,454 million at the end of the previous consolidated fiscal year to ¥2,272 million at the end of the third quarter under review.
  11. FY2023-Q2MitigatedAnnual report

    「Total ¥2,454 million ¥2,371 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,454 million at the end of the previous consolidated fiscal year to ¥2,371 million.
  12. FY2023-Q1MitigatedAnnual report

    「Total ¥2,454 million ¥2,414 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,454 million at the end of FY2022 to ¥2,414 million at the end of FY2023-Q1.
  13. FY2022MitigatedAnnual report

    「Total ¥2,536 million ¥2,454 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,536 million at the end of the previous fiscal year to ¥2,454 million.
  14. FY2022-Q3MitigatedAnnual report

    「Total ¥2,536 million ¥2,502 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,536 million at the end of the previous consolidated fiscal year to ¥2,502 million at the end of the third quarter under review.
  15. FY2022-Q2MitigatedAnnual report

    「Total ¥2,536 million ¥2,530 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,536 million at the end of the previous consolidated fiscal year to ¥2,530 million at the end of the second quarter under review.
  16. FY2022-Q1MitigatedAnnual report

    「Total ¥2,536 million ¥2,507 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,536 million at the end of the previous consolidated fiscal year to ¥2,507 million at the end of the first quarter under review.
  17. FY2021MitigatedAnnual report

    「Total ¥2,690 million ¥2,536 million」

    The balance of guarantees of debt to medical corporations decreased from ¥2,690 million at the end of the previous fiscal year to ¥2,536 million.
  18. FY2021-Q3MitigatedAnnual report

    「Total ¥2,690 million ¥2,485 million」

    The balance of debt guarantees declined from ¥2,690 million at the end of the previous consolidated fiscal year to ¥2,485 million at the end of the third quarter.
  19. FY2021-Q2MitigatedAnnual report

    「Total ¥2,690 million ¥2,524 million」

    The balance of debt guarantees declined from ¥2,690 million at the end of the previous consolidated fiscal year to ¥2,524 million at the end of the second quarter.
  20. FY2021-Q1WorsenedAnnual report

    「The company provides guarantees for borrowings from financial institutions and other lenders by the following medical corporations: Medical Corporation Jukeikai (loan obligations), ¥692 million and ¥824 million; Medical Corporation Nogakikai (loan obligations), ¥211 million and ¥137 million; Social Medical Corporation Hannan Medical and Welfare Center (loan obligations), ¥1,635 million and ¥1,631 million; Medical Corporation Senpakai (loan obligations), ¥0 million and ¥350 million; Medical Corporation Junseikai (loan obligations), ¥0 million and ¥30 million; total, ¥2,540 million and ¥2,972 million.」

    The balance of debt guarantees to medical corporations increased from ¥2,540 million at the end of the previous fiscal year to ¥2,972 million at the end of the first quarter, with new guarantee recipients also added.
  21. FY2020MitigatedAnnual report

    「The company provides guarantees for borrowings from financial institutions and other lenders by the following medical corporations: Medical Corporation Jukeikai (loan obligations), ¥692 million; Medical Corporation Nogakikai (loan obligations), ¥211 million; Social Medical Corporation Hannan Medical and Welfare Center (loan obligations), ¥1,635 million; total, ¥2,540 million.」

    The balance of debt guarantees to medical corporations was ¥2,540 million at the fiscal year-end, down from ¥4,470 million at the end of the previous fiscal year.
  22. FY2020-Q2MitigatedAnnual report

    「Total ¥4,470 million ¥4,328 million」

    The balance of debt guarantees declined from ¥4,470 million at the end of the previous consolidated fiscal year to ¥4,328 million at the end of the second quarter. However, guarantee balances for medical corporation Jukeikai and others continue to be recorded.
  23. FY2020-Q1WorsenedAnnual report

    「The company may provide joint and several guarantees for borrowings by medical institutions with which the group has business alliances, as well as for borrowings by affiliated companies that invest in or lend to medical institutions. Accordingly, if repayment of borrowings guaranteed by the company falls into arrears, the company is jointly and severally liable for repayment of those borrowings.」

    In addition to SPCs and similar entities, borrowings by affiliated companies that invest in or lend to partner medical institutions are also described as subject to guarantees. The balance of guarantee obligations increased from ¥4,470 million at the end of the previous consolidated fiscal year to ¥4,866 million.
  24. FY2019WorsenedAnnual report

    「Total ¥1,724 million ¥5,272 million」

    The balance of debt guarantees increased from ¥1,724 million at the end of the previous consolidated fiscal year to ¥5,272 million, with guarantees to medical corporations and others also added.
  25. FY2019-Q3WorsenedAnnual report

    「Total ¥1,724.648 million Total ¥4,756.748 million」

    The balance of debt guarantees increased from ¥1,724.648 million at the end of the previous consolidated fiscal year to ¥4,756.748 million at the end of the third quarter, expanding the guarantee exposure. Guarantees to medical corporations and others are also recorded.
  26. FY2019-Q2WorsenedAnnual report

    「Guarantee obligations Total ¥1,724.648 million Total ¥4,695.784 million」

    The balance of debt guarantees increased from ¥1,724.648 million at the end of the previous consolidated fiscal year to ¥4,695.784 million at the end of the second quarter, expanding the guarantee exposure. New guarantees to medical corporations and others are also described.
  27. FY2019-Q1WorsenedAnnual report

    「Total ¥1,724.648 million Total ¥1,959.021 million」

    The balance of debt guarantees increased from ¥1,724.648 million at the end of the previous consolidated fiscal year to ¥1,959.021 million at the end of the first quarter, expanding the guarantee exposure.
  28. FY2018WorsenedAnnual report

    「Total ¥1,214.827 million Total ¥1,724.648 million」

    The balance of debt guarantees increased from ¥1,214.827 million at the end of the previous consolidated fiscal year to ¥1,724.648 million, expanding the guarantee exposure.
  29. FY2018-Q3WorsenedAnnual report

    「The company provides guarantees for borrowings by companies other than consolidated companies from financial institutions and other lenders. Total ¥1,692.959 million」

    The total balance of guarantee obligations increased from ¥1,214.827 million at the end of the previous consolidated fiscal year to ¥1,692.959 million at the end of the third quarter, expanding the guarantee exposure.
  30. FY2017First statedAnnual report

    「If an SPC for which the company has provided a joint and several guarantee falls behind on its loan repayments, the company is jointly and severally liable for repayment of the SPC's borrowings.」

    The repayment obligation associated with providing joint and several guarantees for SPC borrowings is described as a risk.
Moved together

"Continued growth in net income attributable to owners of the parent and monitoring of real estate-related indicators" moved the same way as this thread, in the same document, in 12 of its 30 moves.

12117665★123456
  1. ★This thread
  2. 1Continued growth in net income attributable to owners of the parent and monitoring of real estate-related indicators12×
  3. 2Developing the hospital-related business into a growth area and core business11×
  4. 3Risk of Interest Rate Fluctuations and Reliance on Interest-Bearing Debt7×
  5. 4Determination and execution of property exit strategies6×
  6. 5Redemption and going-concern risks from suspension of crowdfunding offerings6×
  7. 6Expanding leasable floor area through the acquisition and leasing of existing facilities5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for GLOME Holdings yet. It last moved in the General Meetings of Shareholders of 2026-05-28: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.